Adrenoblockers Market to Grow at a CAGR of Over 5.6% from 2023 to 2031, reveals Growth Plus Reports

Friday, May 26, 2023 at 6:49am UTC

Newark, New Castle, USA, May 26, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the size of the global market for adrenoblockers in 2022 and is expected to increase at a revenue CAGR of 5.6% by 2031.

Analysis of the global market for adrenoblockers indicates that during the forecast period, revenue share is likely to increase significantly. Alpha and beta blockers, also referred to as adrenalblockers, are a class of drugs that stop the body from responding to adrenaline. 

Key Takeaways: 

  • The increasing number of patients with hypertension and cardiovascular disorders is driving the market revenue share.
  • The rising awareness of advanced therapeutics among the population is driving the market demand.
  • The demand for precise disease treatment is increasing the market revenue growth rapidly.

Get a Free Sample Research Report:

                                                    Adrenoblockers Market Scope

Report AttributeDetails
Base Year for Estimation2022
Forecast Period2023 to 2031
Historical Year2021
Segments CoveredType, Indication, and Region
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Competitive Landscape

A list of the prominent players operating in the global market for adrenoblockers includes: 

  • Pfizer, Inc.   
  • Boehringer Ingelheim Pharmaceuticals, Inc. 
  • Merck KGaA
  • Sanofi-Aventis U.S. LLC.        

Market Drivers and Restraints: 

The global adrenoblockers market revenue is driven by the rising cardiovascular and hypertension patients, rising geriatric population, and growing awareness of precise and advanced therapeutics. 

However, due to the numerous side effects associated with the availability of alternative treatment options, and the unaffordability of these drugs in low-income regions, the adrenoblockers market revenue growth is expected to be restrained. 

Market Segmentation: 

  • Based on types, the adrenoblockers market is segmented into α adrenergic blocking drugs, β adrenergic blocking drugs, α + β adrenergic blockers.
  • Based on indications, the adrenoblockers market is segmented into benign prostatic hypertrophy hypertension, attention-deficit hyperactivity disorder, arrhythmia, and others.

Request for Customization –

Segmentation By Indications

Based on the indications, the hypertension segment dominates the global adrenoblockers market with the largest revenue share. This significant revenue share is because hypertension is becoming more common, and there is a growing need for better treatment solutions.  

Regional Growth Dynamics

Based on the region, North America, with the largest revenue share, dominates the global adrenoblockers market. The region's high frequency of the target disorders is a significant factor contributing to North America's market dominance for adrenoblockers. Furthermore, in North America, the adrenoblockers market is highly competitive and diverse, and a number of businesses support its expansion.

Report Coverage 

Growth Plus Reports conducted extensive research on the world market for adrenoblockers. We looked at the essential market traits, important investment spheres, regional growth analytics, revenue projections, rival market participants, and mergers and acquisitions.

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape
    4. Reimbursement Scenario 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. α Adrenergic Blocking Drugs
    2. β Adrenergic Blocking Drugs
    3. α + β Adrenergic Blockers
    1. Benign prostatic hypertrophy                                    
    2. Hypertension                          
    3. Attention-deficit Hyperactivity Disorder
    4. Arrhythmia 
    5. Others 


Buy this Premium Research Report:


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Schedule a call with our analyst:

Visit our report store at -

Browse more latest healthcare reports:

Retrovirus Testing Market by Test Type (Antibody Test, Antigen/Antibody Test), Technique Type (ELISA, PCR), Sample Type (Serum, Blood) – Global Outlook & Forecast 2023-2031

Southern Blotting Market by Products (Consumables and Instruments), Application (Medical Diagnosis, Genetic Fingerprinting, Scientific Research), End User (Biotechnology & Pharmaceutical Industries, Research Institutes) - Global Outlook and Forecast 2023-2031

Laser Indirect Opthalmoscope Market by Laser Type (Photocoagulating Laser Indirect Ophthalmoscope, Photo Disrupting Laser Indirect Ophthalmoscope), Therapeutic Application (Diabetic Retinopathy, Lattice Degeneration), End User (Ophthalmic Clinics, Multispecialty Hospitals) – Global Outlook & Forecast 2023-2031

AI in Endoscopy Market by Application (Bronchoscopy, Gastrointestinal Endoscopy), Component (Hardware, Software), End User (Hospitals, Ambulatory Care Centers) – Global Outlook & Forecast 2023-2031

Recording Chart Papers Market by Type (Ultrasound / OBGYN Recording Chart Papers, Fetal Monitoring Recording Chart Papers), End User (Hospitals & Clinics, Diagnostic Centers) - Global Outlook & Forecast 2023-2031

Unleashing the Power of Innovation in Med Tech

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Manan Sethi
Director, Market Insights
256 Chapman Road
STE 105-4, Newark,
New Castle - 19702, USA
Phone no: +1 888 550 5009

Primary Logo